GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

6 Months Ended

Apr. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill balances and movements for each reportable segments during the period

The following table presents goodwill balances and the movements for each of our reportable segments during the six months ended April 30, 2017:



	Life Sciences and Applied Markets		Diagnostics and Genomics		Agilent CrossLab			Total
	(in millions)
Goodwill as of October 31, 2016	$	790	$	1,223	$	504		$	2,517
Foreign currency translation impact	—		2		(2		)	—
Goodwill arising from acquisitions	—		51		—			51
Goodwill as of April 30, 2017	$	790	$	1,276	$	502		$	2,568

Components of other intangibles during the period

The components of other intangibles as of April 30, 2017 and October 31, 2016 are shown in the table below:



	Purchased Other Intangible Assets
	Gross Carrying Amount		Accumulated Amortization		Net Book Value
	(in millions)
As of October 31, 2016
Purchased technology	$	823	$	572	$	251
Backlog	1		1		—
Trademark/Tradename	149		61		88
Customer relationships	263		211		52
Total amortizable intangible assets	1,236		845		391
In-Process R&D	17		—		17
Total	$	1,253	$	845	$	408
As of April 30, 2017
Purchased technology	$	836	$	609	$	227
Trademark/Tradename	149		67		82
Customer relationships	146		99		47
Total amortizable intangible assets	1,131		775		356
In-Process R&D	17		—		17
Total	$	1,148	$	775	$	373

Schedule of estimated future amortization expense of finite-lived intangible assets

Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2017 and for each of the five succeeding fiscal years and thereafter is estimated below:



Estimated future amortization expense:
(in millions)
Remainder of 2017	$	53
2018	$	87
2019	$	63
2020	$	52
2021	$	39
2022	$	28
Thereafter	$	34